查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575021

PoC 传染病检测市场，按疾病类型、技术、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

PoC Infectious Disease Testing Market, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，PoC传染病检测市场规模为114.9832亿美元，2024年至2032年复合年增长率为4.40%。

PoC传染病检测市场-市场动态

传染病患者病率的增加以及对快速诊断和数位化的需求预计将推动市场需求

COVID-19、流感、HIV、结核病和性传染感染等传染病的发生率不断增加，提高了对快速、可靠诊断的需求。测试技术的创新，包括 PCR、免疫分析和微流控等分子诊断，提高了 POCT 设备的敏感度、特异性和易用性，从而增加了对 POC 测试的需求。大众对早期诊断和定期筛检的好处的认识也在提高，从而促进了市场的成长。

此外，POCT 无需专门的实验室设施和人员，从而降低了测试的整体成本。 POCT 设备与数位健康平台和电子病历 (EMR) 的整合可实现无缝资料共享、远端监控和改进的疾病管理。新兴经济体正在采用 POCT 解决方案来解决医疗基础设施和技术人员的短缺问题。连接功能可以更好地追踪疾病爆发和流行病学监测。这些好处预计将促进市场成长。

PoC 传染病检测市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 4.40% 左右的复合年增长率成长

根据疾病类型细分，由于对快速诊断的高度需求，预计 COVID-19 疾病细分市场将在 2023 年显示最大的市场份额。

从技术细分来看，由于分子检测的发展，分子诊断细分市场将成为2023年领先的技术细分市场。

根据最终用户细分，由于 POC 诊断实验室、中心等数量不断增加，诊所细分市场将在 2023 年成为领先的最终用户细分市场。

按地区划分，由于拥有先进的医疗保健技术和基础设施，北美将成为 2023 年领先的收入来源。

PoC传染病检测市场-細項分析：

全球 PoC 传染病检测市场根据疾病类型、技术、最终用户和地区进行细分。

根据疾病类型，市场分为七类：HIV、流感、结核病和抗药性 POC、HBV POC、HPV POC、COVID-19 疾病等。 COVID-19 疾病领域主导市场。 COVID-19 PCR 检测需求的不断增长推动了该细分市场的成长。

市场依技术分为四大类：侧流免疫分析、凝集试验、分子诊断等。分子诊断领域主导市场。分子测试是准确的，并且在遗传材料加工中是首选，这正在加速细分市场的需求。

根据最终用户，市场分为四大类：医院、诊所、家庭护理等。诊所领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。提供 POC 传染病快速治疗的临床中心数量不断增加，正在推动市场成长。

PoC传染病检测市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美，尤其是美国，由于其先进的医疗基础设施、高疾病负担以及对快速诊断的高度重视，在全球 POCT 市场中占据最大份额。由于人口基数大、传染病患者病率上升以及早期诊断意识不断增强，亚太地区预计将出现最高的成长率。 POCT 在农村和偏远地区的采用率特别高，以解决缺乏集中实验室设施的问题。

PoC传染病检测市场-竞争格局：

PoC 传染病检测市场竞争激烈，其特点是存在许多全球和区域参与者。公司越来越多地投资将数位健康解决方案（例如基于云端的资料管理和远端监控）整合到其 POCT 产品中。此外，该公司还致力于透过基于 CRISPR 的诊断和自动数位阅读器等下一代技术来提高 POCT 设备的灵敏度和特异性。

2024年1月，罗氏完成了LumiraDx的床边技术的收购。 LumiraDx 的平台包括一系列免疫测定和临床化学测试。

2023 年 2 月，赛默飞世尔科技与 Mylab 合作，在印度推出针对传染病的 RTPCR 试剂盒。

目录

第 1 章：PoC 传染病检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疾病类型分類的 PoC 传染病检测市场片段
    • PoC 传染病检测市场技术片段
    • 最终用户的 PoC 传染病检测市场片段
    • 按国家/地区分類的 PoC 传染病检测市场片段
    • 按地区分類的 PoC 传染病检测市场片段
  • 竞争洞察

第 3 章：PoC 传染病检测主要市场趋势

  • PoC 传染病检测市场驱动因素
    • 市场驱动因素的影响分析
  • PoC传染病检测市场限制
    • 市场限制影响分析
  • PoC传染病检测市场机会
  • PoC传染病检测市场未来趋势

第 4 章：PoC 传染病检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：PoC 传染病检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：PoC 传染病检测市场格局

  • 2023 年 PoC 传染病检测市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：PoC 传染病检测市场 - 依疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 爱滋病
    • 流感
    • 结核病和抗药性 POC
    • 乙肝病毒POC
    • HPV POC
    • COVID-19 疾病
    • 其他的

第 8 章：PoC 传染病检测市场 - 依技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 侧流免疫分析
    • 凝集试验
    • 分子诊断
    • 其他的

第 9 章：PoC 传染病检测市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 居家护理
    • 其他的

第 10 章：PoC 传染病检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • PoC传染病检测北美主要厂商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • PoC传染病检测欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太区PoC传染病检测主要厂商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • PoC传染病检测拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • PoC传染病检测中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第11章：PoC传染病检测产业主要供应商分析

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Roche Diagnostics
    • QuidelOrtho Corporation
    • Siemens Healthineers
    • Becton, Dickinson and Company
    • Cepheid
    • bioMerieux
    • Thermo Fisher Scientific
    • Hologic, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific
    • Chembio Diagnostics, Inc.
    • PerkinElmer, Inc.
    • Sekisui Diagnostics
    • Trinity Biotech plc
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3976

REPORT HIGHLIGHT

PoC Infectious Disease Testing Market size was valued at USD 11,498.32 Million in 2023, expanding at a CAGR of 4.40% from 2024 to 2032.

Point of Care Infectious Disease Testing (POCT) refers to diagnostic tests conducted at or near the site of patient care, such as in a clinic, doctor's office, or at home. These tests are designed to detect infectious diseases quickly, providing results within minutes to a few hours. This enables healthcare providers to make immediate decisions about treatment and management, reducing the need for additional lab testing and follow-up visits.

PoC Infectious Disease Testing Market- Market Dynamics

Increasing prevalence of infectious diseases and need for rapid diagnostics along with digitization is expected to propel market demand

The increasing incidence of infectious diseases like COVID-19, influenza, HIV, tuberculosis, and sexually transmitted infections has heightened the demand for rapid and reliable diagnostics. Innovations in testing technologies, including molecular diagnostics like PCR, immunoassays, and microfluidics, have improved the sensitivity, specificity, and ease of use of POCT devices, boosting demand for POC testing. Public awareness regarding the benefits of early diagnosis and regular screening is also rising, contributing to market growth.

Further, POCT reduces the overall cost of testing by eliminating the need for specialized lab facilities and personnel. Integration of POCT devices with digital health platforms and electronic medical records (EMRs) allows for seamless data sharing, remote monitoring, and improved disease management. Emerging economies are adopting POCT solutions to address the shortage of healthcare infrastructure and skilled personnel. Connectivity features enable better tracking of disease outbreaks and epidemiological surveillance. These benefits are expected to bolster market growth.

PoC Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.40% over the forecast period (2024-2032)

Based on Disease Type segmentation, the COVID-19 disease segment was predicted to show maximum market share in the year 2023, owing to high need for fast diagnostics.

Based on Technology segmentation, molecular diagnostics segment was the leading Technology segment in 2023, due to the developments in molecular testing.

Based on End User segmentation, clinics segment was the leading End User segment in 2023, due to increasing number of POC diagnostics labs, centers, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of advanced healthcare technology and infrastructure.

PoC Infectious Disease Testing Market- Segmentation Analysis:

Global PoC Infectious Disease Testing Market is segmented on the basis of Disease Type, Technology, End User, and Region.

The market is divided into seven categories based on Disease Type: HIV, influenza, TB & drug resistant POC, HBV POC, HPV POC, COVID-19 disease, and others. The COVID-19 disease segment dominates the market. The increasing demand from PCR testing for COVID-19 has boosted segment growth.

The market is divided into four categories based on Technology: lateral flow immunoassay, agglutination test, molecular diagnostics, and others. The molecular diagnostics segment dominates the market. The molecular tests are accurate and preferred in genetic material processing which is accelerating segment demand.

The market is divided into four categories based on End User: hospitals, clinics, homecare, and others. The clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising number of clinical centers providing rapid treatment in POC infectious diseases is boosting market growth.

PoC Infectious Disease Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, particularly the United States, holds the largest share of the global POCT market due to its advanced healthcare infrastructure, high disease burden, and strong emphasis on rapid diagnostics. The Asia-Pacific region is expected to witness the highest growth rate due to the large population base, rising prevalence of infectious diseases, and growing awareness about early diagnosis. The adoption of POCT is particularly high in rural and remote areas to address the lack of access to centralized laboratory facilities.

PoC Infectious Disease Testing Market- Competitive Landscape:

The PoC Infectious Disease Testing market is highly competitive and characterized by the presence of numerous global and regional players. Companies are increasingly investing in integrating digital health solutions, such as cloud-based data management and remote monitoring, into their POCT products. In addition, companies are focusing on enhancing the sensitivity and specificity of their POCT devices through next-generation technologies, such as CRISPR-based diagnostics, and automated digital readers.

In January 2024, Roche completed acquisition of LumiraDx's point of care technology. The LumiraDx's platform includes a series of immunoassay and clinical chemical tests.

In February 2023, Thermo Fisher Scientific partnered with Mylab to introduce RTPCR kits for infectious disease in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche Diagnostics
  • QuidelOrtho Corporation
  • Siemens Healthineers
  • Becton, Dickinson and Company
  • Cepheid
  • bioMerieux
  • Thermo Fisher Scientific
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Chembio Diagnostics, Inc.
  • PerkinElmer, Inc.
  • Sekisui Diagnostics
  • Trinity Biotech plc
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • HIV
  • Influenza
  • TB & drug resistant POC
  • HBV POC
  • HPV POC
  • COVID-19 disease
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

  • Lateral flow immunoassay
  • Agglutination test
  • Molecular diagnostics
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Clinics
  • Homecare
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PoC Infectious Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PoC Infectious Disease Testing Market Snippet by Disease Type
    • 2.1.2. PoC Infectious Disease Testing Market Snippet by Technology
    • 2.1.3. PoC Infectious Disease Testing Market Snippet by End User
    • 2.1.4. PoC Infectious Disease Testing Market Snippet by Country
    • 2.1.5. PoC Infectious Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. PoC Infectious Disease Testing Key Market Trends

  • 3.1. PoC Infectious Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PoC Infectious Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PoC Infectious Disease Testing Market Opportunities
  • 3.4. PoC Infectious Disease Testing Market Future Trends

4. PoC Infectious Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PoC Infectious Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PoC Infectious Disease Testing Market Landscape

  • 6.1. PoC Infectious Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PoC Infectious Disease Testing Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. HIV
    • 7.1.3. Influenza
    • 7.1.4. TB & drug resistant POC
    • 7.1.5. HBV POC
    • 7.1.6. HPV POC
    • 7.1.7. COVID-19 disease
    • 7.1.8. Others

8. PoC Infectious Disease Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Lateral flow immunoassay
    • 8.1.3. Agglutination test
    • 8.1.4. Molecular diagnostics
    • 8.1.5. Others

9. PoC Infectious Disease Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Clinics
    • 9.1.4. Homecare
    • 9.1.5. Others

10. PoC Infectious Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PoC Infectious Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PoC Infectious Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PoC Infectious Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PoC Infectious Disease Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PoC Infectious Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PoC Infectious Disease Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. QuidelOrtho Corporation
    • 11.2.4. Siemens Healthineers
    • 11.2.5. Becton, Dickinson and Company
    • 11.2.6. Cepheid
    • 11.2.7. bioMerieux
    • 11.2.8. Thermo Fisher Scientific
    • 11.2.9. Hologic, Inc.
    • 11.2.10. Bio-Rad Laboratories, Inc.
    • 11.2.11. Thermo Fisher Scientific
    • 11.2.12. Chembio Diagnostics, Inc.
    • 11.2.13. PerkinElmer, Inc.
    • 11.2.14. Sekisui Diagnostics
    • 11.2.15. Trinity Biotech plc
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us